Novavax COVID-19 vaccine 90% efficacious in phase 3, could boost world’s supply : Research head
US biotechnology major Novavax on Wednesday claimed 2 huge phase-3 trials of its Covid -19 vaccine being manufactured by Pune-based Product Institute of India have actually revealed that the jab provides high levels of protection versus light, modest, and also extreme infection. Talking at SII, Dr Gregory Glenn, head of state of Research and…